| 1 |
pH-activatable polymeric nanodrugs enhanced tumor chemo/antiangiogenic combination therapy through improving targeting drug release
Xiong H, Wu YY, Jiang ZJ, Zhou JP, Yang M, Yao J
Journal of Colloid and Interface Science, 536, 135, 2019 |
| 2 |
Recombinant Escherichia coli K5 strain with the deletion of waaR gene decreases the molecular weight of the heparosan capsular polysaccharide
Huang HC, Liu XB, Lv SC, Zhong WH, Zhang FM, Linhardt RJ
Applied Microbiology and Biotechnology, 100(18), 7877, 2016 |
| 3 |
Heparinase I-specific disaccharide unit of heparin is a key structure but insufficient for exerting anti-prion activity in prion-infected cells
Teruya K, Wakao M, Sato M, Hamanaka T, Nishizawa K, Funayama Y, Sakasegawa Y, Suda Y, Doh-ura K
Biochemical and Biophysical Research Communications, 460(4), 989, 2015 |
| 4 |
Neuroprotective Effects of Ultra-Low-Molecular-Weight Heparin on Cerebral Ischemia/Reperfusion Injury in Rats: Involvement of Apoptosis, Inflammatory Reaction and Energy Metabolism
Zhang ZG, Sun X, Zhang QZ, Yang H
International Journal of Molecular Sciences, 14(1), 1932, 2013 |
| 5 |
Linear polyalkylamines as fingerprinting agents in capillary electrophoresis of low-molecular-weight heparins and glycosaminoglycans
King JT, Desai UR
Electrophoresis, 32(21), 3070, 2011 |
| 6 |
Sustained release of low molecular weight heparin from PLGA microspheres prepared by a solid-in-oil-in-water emulsion method
He JT, Zhou ZT, Fan YY, Zhou XL, Du HJ
Journal of Microencapsulation, 28(8), 763, 2011 |
| 7 |
Selective cleavage of heparin using aqueous 2-hydroxypyridine: Production of an aldose-terminating fragment with high anticoagulant activity
Berry LR, Parmar N, Hatton MWC, Chan AKC
Biochemical and Biophysical Research Communications, 346(3), 946, 2006 |
| 8 |
Immobilization of recombinant heparinase I fused to cellulose-binding domain
Shpigel E, Goldlust A, Efroni G, Avraham A, Eshel A, Dekel M, Shoseyov O
Biotechnology and Bioengineering, 65(1), 17, 1999 |
